Zealand Pharma
Clinical trials sponsored by Zealand Pharma, explained in plain language.
-
New drug aims to free patients from IV dependence
Disease control Recruiting nowThis study is testing whether a new injectable drug called glepaglutide can help adults with short bowel syndrome. The goal is to see if taking the drug twice a week can safely reduce the amount of intravenous (IV) fluids and nutrition they need. About 90 participants will receiv…
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
First humans receive experimental drug ZP9830 in safety test
Knowledge-focused Recruiting nowThis is the first study testing a new drug called ZP9830 in humans. Researchers will give the drug to 124 healthy volunteers to check for side effects and see how the body handles it. The study will compare people who get the real drug to those who get a placebo (inactive substan…
Phase: PHASE1 • Sponsor: Zealand Pharma • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC